Vizient Assesses the Challenges for Hospitals in Evaluating and Adopting Innovative Medical Devices
April 09, 2019 IRVING, Texas–(BUSINESS WIRE)–Over the last six years, the U.S. Food and Drug Administration has approved a number of highly innovative medical devices that have revolutionized cardiovascular care. These novel devices have provided advanced treatment options, improved quality of life and extended longevity for patients. Unfortunately, reimbursement has often failed to keep up with many of increasingly expensive treatment options. In the report, “The cost of medical device innovation: can we keep pace?”